Literature DB >> 15258002

Estimating laboratory precision of urinary albumin excretion and other urinary measures in the International Study on Macronutrients and Blood Pressure.

Alan R Dyer1, Philip Greenland, Paul Elliott, Martha L Daviglus, George Claeys, Hugo Kesteloot, Queenie Chan, Hirotsugu Ueshima, Jeremiah Stamler.   

Abstract

Microalbuminuria is a risk factor for renal failure, stroke, and cardiovascular disease. However, estimating laboratory precision for albumin excretion is problematic because of its highly skewed distribution and the presence of values below assay detection limits. The authors used 781 quality control pairs from 24-hour urine samples collected between 1996 and 1999 in the International Study on Macronutrients and Blood Pressure (INTERMAP) to compare percentage of technical error (%TE), the usual estimate of laboratory precision, with the mean and median values of within-pair coefficients of variation (CVs) for urinary albumin concentration and other urinary variables. In INTERMAP, %TE was larger than mean CV for all variables. Exclusion of potentially mislabeled samples reduced this difference; for example, for sodium, estimates of %TE and mean and median CV were 2.37%, 0.75%, and 0.28%, respectively, for all 781 pairs and 0.84%, 0.48%, and 0.27%, respectively, with possibly mislabeled pairs excluded. For urinary albumin concentration, exclusion of one mislabeled pair changed estimates for %TE and mean CV from 29.6% and 20.8% to 20.6% and 20.6%, while median CV was unchanged at 9.4%. After exclusion of urinary albumin concentration pairs with values below the detection limit, estimates were 15.4%, 11.4%, and 6.4%, respectively. Results indicate that mean and median CV are not equivalent to %TE and that values below the detection limit can markedly affect estimates and should be excluded.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15258002      PMCID: PMC6556774          DOI: 10.1093/aje/kwh196

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  27 in total

Review 1.  Laboratory issues: use of nutritional biomarkers.

Authors:  Heidi Michels Blanck; Barbara A Bowman; Gerald R Cooper; Gary L Myers; Dayton T Miller
Journal:  J Nutr       Date:  2003-03       Impact factor: 4.798

Review 2.  Microalbuminuria: how informative and reliable are individual measurements?

Authors:  Richard Donnelly; Rustam Rea
Journal:  J Hypertens       Date:  2003-07       Impact factor: 4.844

3.  Arterial hypertension, microalbuminuria, and risk of ischemic heart disease.

Authors:  J S Jensen; B Feldt-Rasmussen; S Strandgaard; M Schroll; K Borch-Johnsen
Journal:  Hypertension       Date:  2000-04       Impact factor: 10.190

4.  Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.

Authors:  Coen D A Stehouwer; Mari-Anne Gall; Jos W R Twisk; Elisabeth Knudsen; Jef J Emeis; Hans-Henrik Parving
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

5.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

6.  Microalbuminuria in ischemic stroke.

Authors:  N B Beamer; B M Coull; W M Clark; M Wynn
Journal:  Arch Neurol       Date:  1999-06

7.  Urinary albumin excretion. An independent predictor of ischemic heart disease.

Authors:  K Borch-Johnsen; B Feldt-Rasmussen; S Strandgaard; M Schroll; J S Jensen
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-08       Impact factor: 8.311

8.  Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women.

Authors:  M Roest; J D Banga; W M Janssen; D E Grobbee; J J Sixma; P E de Jong; D de Zeeuw; Y T van Der Schouw
Journal:  Circulation       Date:  2001-06-26       Impact factor: 29.690

9.  Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study.

Authors:  A Jager; P J Kostense; H G Ruhé; R J Heine; G Nijpels; J M Dekker; L M Bouter; C D Stehouwer
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

10.  Freezing method affects the concentration and variability of urine proteins and the interpretation of data on microalbuminuria. The Oxford Regional Prospective Study Group.

Authors:  C J Schultz; R N Dalton; C Turner; H A Neil; D B Dunger
Journal:  Diabet Med       Date:  2000-01       Impact factor: 4.359

View more
  3 in total

1.  Leptin links with plasminogen activator inhibitor-1 in human obesity: the SABPA study.

Authors:  Chiné Pieterse; Rudolph Schutte; Aletta E Schutte
Journal:  Hypertens Res       Date:  2015-03-05       Impact factor: 3.872

2.  Metabolic profiling strategy for discovery of nutritional biomarkers: proline betaine as a marker of citrus consumption.

Authors:  Silke S Heinzmann; Ian J Brown; Queenie Chan; Magda Bictash; Marc-Emmanuel Dumas; Sunil Kochhar; Jeremiah Stamler; Elaine Holmes; Paul Elliott; Jeremy K Nicholson
Journal:  Am J Clin Nutr       Date:  2010-06-23       Impact factor: 7.045

3.  Blood pressure interactions with the DASH dietary pattern, sodium, and potassium: The International Study of Macro-/Micronutrients and Blood Pressure (INTERMAP).

Authors:  Queenie Chan; Gina M Wren; Chung-Ho E Lau; Timothy M D Ebbels; Rachel Gibson; Ruey Leng Loo; Ghadeer S Aljuraiban; Joram M Posma; Alan R Dyer; Lyn M Steffen; Beatriz L Rodriguez; Lawrence J Appel; Martha L Daviglus; Paul Elliott; Jeremiah Stamler; Elaine Holmes; Linda Van Horn
Journal:  Am J Clin Nutr       Date:  2022-07-06       Impact factor: 8.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.